EHA Preview: Agios Takes Spotlight In Thalassemia

 
• By Andrew McConaghie

The company expects to have data from transfusion-dependent and non-transfusion dependent patients this year, with a potential expanded US approval in 2025 for Pyrukynd.

IFEMA Madrid
The European Hematology Association congress will take place in Madrid, Spain, 13-16 June. • Source: Shutterstock

More from Business

More from Scrip